General Information of the Compound
| Compound ID |
CP0921304
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(5-(3-cyano-7-(oxetan-3-ylamino)pyrazolo[1,5-a]pyrimidin-5-ylamino)-2-cyclopropylphenyl)acetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H21N7O2
|
||||||||||||||||||
| Molecular Weight |
403.446
|
||||||||||||||||||
| Canonical SMILES |
CC(=O)Nc1cc(Nc2cc(NC3COC3)n3ncc(C#N)c3n2)ccc1C1CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H21N7O2/c1-12(29)24-18-6-15(4-5-17(18)13-2-3-13)25-19-7-20(26-16-10-30-11-16)28-21(27-19)14(8-22)9-23-28/h4-7,9,13,16,26H,2-3,10-11H2,1H3,(H,24,29)(H,25,27)
Show/Hide
|
||||||||||||||||||
| InChIKey |
QDTAMOQNSBQTOV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01210, Casein kinase II subunit alpha
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2